Droplet Biosciences is a liquid biopsy company focused on improving cancer care through the analysis of lymphatic fluid harvested from surgical drains to detect molecular residual disease (MRD)
Droplet Biosciences is a liquid biopsy company focused on improving cancer care through the analysis of lymphatic fluid harvested from surgical drains to detect molecular residual disease (MRD). Their technology aims to enhance the detection of circulating tumor DNA (ctDNA) and guide post-surgery treatment decisions.